XorphanolAlternative Names: TR 5379; TR 5379M
Latest Information Update: 08 Feb 2008
At a glance
- Originator HG Pars
- Class Opioid analgesics
- Mechanism of Action Opioid kappa receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 17 Jul 1998 No-Development-Reported for Pain in USA (PO)
- 11 Oct 1995 A comparative clinical study has been added to the pharmacodynamics and adverse events sections